Research on Pathomechanism and a novel treatment of HTLV-I-associated myelopathy (HAM)
Research on Pathomechanism and a novel treatment of HTLV-I-associated myelopathy (HAM)
批准号:
09470155
负责人:
OSAME Mitsuhiro
金额:
$8.26万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
点击翻译按钮获取中文摘要
英文摘要
HTLV-I proviral load in peripheral blood mononuclear cells (PBMC) from a large number of HAM/TSP patients and asymptomatic HTLV-I carriers were measured to explored the importance of HTLV-I proviral load to the pathomechanism of HAM.The proviral load was measured by an accurate and reproducible quantitative PCR method using a dual-labeled fluorogenic probe (ABI PRISM 7700 Sequence Detection System). The mean +1- standard error of mean (s.e.m.) HTLV-I proviral copy number per 1 x 10(4) PBMC was 798 1- 51 (median 544) in 202 HAM/TSP patients ; 120 +1- 17 (median 34) in 200 non HAM-related (general) asymptomatic HTLV-I carriers (RC) ; and 496 +/- 82 (median 321) in 43 asymptomatic HTLV-I carriers genetically related to HAM/TSP patients (FA). The prevalence of HAM/TSP rises exponentially with log (proviral load) once the proviral load exceeds 1% PBMC.The HTLV-I proviral load of female patients with HAM/TSP was significantly higher than that of male patients, however there was no significan … More t difference in proviral load between sexes in RC.There was a significant correlation between the proviral load and the concentration of neopterin in CSF of HAM/TSP patients. These results indicate that the HTLV-I proviral load in PBMC may be related to the inflammatory process in the spinal cord lesion. The increased proviral load in FA suggests the existence of genetic factors contributing to the replication of HTLV-I in vivo. Furthermore in order to elucidate the localization of HTLV-I proviral DNA directly, we performed double staining using immunohistochemistry and PCR in situ hybridization (PCR-ISH). Fresh frozen sections of the spinal cord from four HAM patients taken at autopsy were first immunostained with antibodies to pan T cells (UCHL-1), macrophages (KP-1) and helper/inducer T cells (OPD4). Then PCR-ISH was carried out with specific primers and probe for the HTLV-I pX region. UCHL- 1-positive cells were noted around perivascular areas and, to some extent, in the parenchyma. Of the UCHL-1-positive cells, 9.4% (case 1), 9.6% (case 2), 1.1% (case 3) and 6.7% (case 4) became positive in HTLV-I PCR-ISH.UCHL-1-negative cells were HTLV-I PCR-ISH negative and almost all KP-l-positive cells were HTLV-I negative. HTLV-I was localized to OPD4-positive cells in examined lesions of cases 2 and 4. These data are a direct demonstration of HTLV-1 proviral DNA localizing to infiltrated T cells in HAM/TSP spinal cord lesions. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kawahigashi, N.et al.: "Predominant expression of Fas ligand mRNA in CD8+ T lymphocytes in patients with HTLV-1 associated myelopathy." J Neuroimmunol. 90 (2). 199-206 (1998)
Kawahigashi, N.等人:“HTLV-1 相关脊髓病患者 CD8 T 淋巴细胞中 Fas 配体 mRNA 的主要表达。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kasai, T.et al.: "A rat model of human T lymphocyte virus type I (HTLV-I) infection : in situ detection of HTLV-I provirus DNA in microglia/macrophages in affected spinal cords of rats with HTLV-I-induced chronic progressive myeloneuropathy." Acta Neuropa
Kasai, T.等人:“人类 T 淋巴细胞病毒 I 型 (HTLV-I) 感染的大鼠模型:在 HTLV-I 大鼠受影响脊髓的小胶质细胞/巨噬细胞中原位检测 HTLV-I 原病毒 DNA
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yamano Y., et al.: "Alteration of cytokine levels by fosfomycin and prednisolone in spontaneous proliferation of cultured lymphocytes from patients with HTLV-I-associated myelopathy (HAM/TSP)" J Neurol Sci.151. 163-167 (1997)
Yamano Y. 等人:“磷霉素和泼尼松龙对来自 HTLV-I 相关脊髓病 (HAM/TSP) 患者的培养淋巴细胞自发增殖的细胞因子水平的改变”J Neurol Sci.151。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Inoue A,et al.: "Detection of the soluble form of the Fas molecule in patients with multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy." J Neuroimmunol.75. 141-146 (1997)
Inoue A 等人:“检测多发性硬化症和人类 T 淋巴细胞病毒 I 型相关脊髓病患者中可溶形式的 Fas 分子。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Exploitation of new therapies for HTLV-I-assotiated myelopathy
-
批准号:14207031
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$23.71万
-
财政年份:2002
-
负责人:OSAME Mitsuhiro
-
依托单位:
HAMの臨床病態・発症機序の解明並びに新治療法の開発に関する研究
-
批准号:11470146
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.15万
-
财政年份:1999
-
负责人:OSAME Mitsuhiro
-
依托单位:
Pathology and Molecular Evolution of HTLV in Asia
-
批准号:07042008
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$10.24万
-
财政年份:1995
-
负责人:OSAME Mitsuhiro
-
依托单位:
Epidemiology and pathology of human retrovirus infection
-
批准号:06042013
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$3.26万
-
财政年份:1994
-
负责人:OSAME Mitsuhiro
-
依托单位:
Epidemiology and pathology of human retro virus infection.
-
批准号:04042017
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$7.3万
-
财政年份:1992
-
负责人:OSAME Mitsuhiro
-
依托单位:
RESEARCH FOR THE PATHOMECHANISM, EPIDEMILOGY AND TREATMENTS FOR HAM AND HTLV-I RELATED DISORDERS.
-
批准号:03454219
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.97万
-
财政年份:1991
-
负责人:OSAME Mitsuhiro
-
依托单位:
Research of Clinical Features and Pathomechanism of HAM
-
批准号:62480208
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.22万
-
财政年份:1987
-
负责人:OSAME Mitsuhiro
-
依托单位:
海外基金